Cargando…

Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy

Type I interferonopathies are monogenic disorders characterized by enhanced type I interferon (IFN-I) cytokine activity. Inherited USP18 and ISG15 deficiencies underlie type I interferonopathies by preventing the regulation of late responses to IFN-I. Specifically, USP18, being stabilized by ISG15,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruber, Conor, Martin-Fernandez, Marta, Ailal, Fatima, Qiu, Xueer, Taft, Justin, Altman, Jennie, Rosain, Jérémie, Buta, Sofija, Bousfiha, Aziz, Casanova, Jean-Laurent, Bustamante, Jacinta, Bogunovic, Dusan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2020
Materias:	Brief Definitive Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201920/ https://www.ncbi.nlm.nih.gov/pubmed/32092142 http://dx.doi.org/10.1084/jem.20192319

Ejemplares similares

A partial form of inherited human USP18 deficiency underlies infection and inflammation
por: Martin-Fernandez, Marta, et al.
Publicado: (2022)

Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome
por: Meuwissen, Marije E.C., et al.
Publicado: (2016)

Type I IFN is siloed in endosomes
por: Altman, Jennie B., et al.
Publicado: (2020)

A Novel Homozygous p.R1105X Mutation of the AP4E1 Gene in Twins with Hereditary Spastic Paraplegia and Mycobacterial Disease
por: Kong, Xiao-Fei, et al.
Publicado: (2013)

Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021)

Chronic upper airway inflammation related to high Th2 cytokines in Mendelian susceptibility to mycobacterial disease case
por: Benhsaien, Ibtihal, et al.
Publicado: (2022)

Type I Interferonopathy due to a Homozygous Loss-of-Inhibitory Function Mutation in STAT2
por: Zhu, Gaofeng, et al.
Publicado: (2023)

ISG15 deficiency restricts HIV-1 infection
por: Jurczyszak, Denise, et al.
Publicado: (2022)

Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022)

Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020)

Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023)

Homozygous variant p. Arg90His in NCF1 is associated with early-onset Interferonopathy: a case report
por: Schnappauf, Oskar, et al.
Publicado: (2021)

Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
por: Moriya, Kunihiko, et al.
Publicado: (2023)

Type I interferonopathies in pediatric rheumatology
por: Volpi, Stefano, et al.
Publicado: (2016)

Type I Interferonopathies in Children: An Overview
por: d'Angelo, Debora M., et al.
Publicado: (2021)

The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021)

Comment on: homozygous variant p. Arg90His in NCF1 is associated with early-onset interferonopathy: a case report
por: Goulielmos, George N., et al.
Publicado: (2021)

Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)

Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X
por: Naik, Edwina, et al.
Publicado: (2014)

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
por: Sanchez, Gina A. Montealegre, et al.
Publicado: (2018)

Covid-19–Associated Myopathy Caused by Type I Interferonopathy
por: Manzano, Giovanna S., et al.
Publicado: (2020)

Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation
por: Vogt, Guillaume, et al.
Publicado: (2008)

ZBP1 contributes to interferonopathies caused by impaired ADAR1 function
por: Fang, Xiuwu, et al.
Publicado: (2022)

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition
por: Galbraith, Matthew D., et al.
Publicado: (2023)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Tanaka, Shiho, et al.
Publicado: (2021)

Inflammatory Cytokine Profiles During Exercise in Obese, Diabetic, and Healthy Children
por: Galassetti, Pietro R., et al.
Publicado: (2011)

Complementary and Alternative Medicine in Children with Type 1 Diabetes Mellitus
por: Haliloglu, Belma, et al.
Publicado: (2011)

3M Syndrome: A Report of Four Cases in Two Families
por: Güven, Ayla, et al.
Publicado: (2011)

Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy
por: Duncan, Christopher James Arthur, et al.
Publicado: (2021)

Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
por: Kim, Hanna, et al.
Publicado: (2020)

Interferonopathies masquerading as non-Mendelian autoimmune diseases: pattern recognition for early diagnosis
por: Gagne, Samuel, et al.
Publicado: (2023)

HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies
por: Marié, Isabelle J., et al.
Publicado: (2018)

Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome
por: Dell’Isola, Giovanni Battista, et al.
Publicado: (2023)

Syndrome d’activation macrophagique compliquant une lymphohistiocytose familiale
por: Boussaadni, Yousra El, et al.
Publicado: (2017)

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
por: Puel, Anne, et al.
Publicado: (2010)

STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function
por: Wilson, Robert P., et al.
Publicado: (2015)

Mosaic tetrasomy 9p: a mendelian interferonopathy associated with pediatric-onset overlap myositis
por: Frémond, M-L, et al.
Publicado: (2015)

Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
por: Rodero, Mathieu P., et al.
Publicado: (2016)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Fine-tuning of type I IFN-signaling in microglia — implications for homeostasis, CNS autoimmunity and interferonopathies
por: Goldmann, Tobias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nafk40gchakv5gtgbn7uokgf49